<- Go Home
Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Market Cap
$8.1K
Volume
141.7K
Cash and Equivalents
$137.4K
EBITDA
-$11.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$1.5M
Profit Margin
N/A
52 Week High
$0.27
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
$19.5M
Enterprise Value / EBITDA
-1.73
Operating Income
-$11.8M
Return on Equity
76.94%
Return on Assets
-81.19
Cash and Short Term Investments
$137.4K
Debt
$19.6M
Equity
-$17.8M
Revenue
N/A
Unlevered FCF
-$6.0M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium